Insurance for Manufacturers, Importers, and Distributors of Medical Devices and IVDs

What Is Medical Device Manufacturer Liability Insurance?

Medical device manufacturer liability insurance provides coverage against civil liability for bodily injury and property damage caused by product use. In the event of an incident, it covers claims from patients, healthcare institutions, and regulatory bodies. This policy is a key element of operational risk management. Proof of financial coverage should be included in the QMS documentation and fall under the responsibility of the Person Responsible for Regulatory Compliance (PRRC).

Insurance Obligations Under MDR and IVDR

According to Article 10(16) of the MDR and Article 10(15) of the IVDR, every manufacturer must ensure sufficient financial coverage, proportionate to the risk, device class, and scale of operations. This also applies to custom-made devices. Although the regulations don’t explicitly require liability insurance, having such a policy is a practical method of fulfilling this obligation. MDCG 2022-16 highlights adequate insurance as a factor in a notified body’s trust in the manufacturer’s ability to manage liability.

Scope of Coverage in Manufacturer Liability Policies

Insurance coverage should include:

• damages caused by defective or poorly designed products,
• costs related to legal proceedings, settlements, and compensation,
• claims from foreseeable but improper use of the product.

It is advisable to include clauses for active devices, implantables, Class D IVDs, and exports to high-risk jurisdictions (e.g., USA, Canada, Asia).

Types of Insurance for Medical Device Manufacturers

Common insurance policies for manufacturers include:

• Product liability insurance – covers damages caused after the product is marketed,
• Operational liability insurance – covers production, packaging, and transport risks,
• Legal protection insurance – covers legal costs in disputes,
• Additional clauses – e.g., for export outside the EU, high-risk products, or implants.

Manufacturers outside the EU must also register as economic operators in EUDAMED, with financial documentation supporting the registration.

The Role of Insurance During MDR Audits

During conformity assessments, notified bodies may request proof of a valid liability insurance policy. Insurance documentation, as part of financial coverage, should be integrated with the technical documentation. For collaborations with foreign notified bodies, an English version of the document is recommended. Auditors may also verify if the policy limit corresponds to the declared product risk and ISO 14971 documentation.

Supply Chain Liability and Insurance Obligations

Under Article 11 of the MDR, the authorized representative of a non-EU manufacturer shares joint liability. Distributors and importers are not required to hold liability insurance but may be held liable for improper storage, transport, or failure to act on an incident. Increasingly, policies include coverage for EU representatives and subrogation clauses among supply chain entities.

Consequences of Inadequate Financial Coverage

Lack of liability insurance can result in:

• refusal or suspension of MDR/IVDR certification,
• full civil liability for the manufacturer, payable from company assets,
• loss of trust from notified bodies and business partners,
• violation of Article 10 MDR/IVDR, potentially leading to regulatory sanctions or product withdrawal.

In the event of an incident, lack of insurance may prevent effective FSCA implementation and lead to mandatory product destruction at the manufacturer’s expense.

How to Select the Right Insurance Policy

Insurance selection should be based on device class, intended use, sales scale, and target markets. Considerations include:

• history of complaints and incident reports,
• whether the device is active, implantable, or intended for high-risk populations,
• territorial scope – EU, USA, UK, Asia,
• alignment of contract terms with MDR/IVDR obligations.

This analysis should be documented in the quality system as part of management reviews and financial supplier evaluations.

How Pure Clinical Supports Financial Coverage Compliance

Pure Clinical supports manufacturers in implementing systems aligned with Article 10 MDR/IVDR through:

• selection and negotiation of insurance policies tailored to classification and intended use,
• risk assessment based on ISO 14971 and integration into technical documentation,
• preparation of financial coverage documentation for audit purposes,
• training for RA/QA teams on insurance as part of the quality system,
• policy compliance checks against MDCG 2022-16 and notified body requirements.

FAQ

What makes an insurance policy “sufficient” from the perspective of a Notified Body?

A sufficient policy covers EU jurisdiction, matches the device's risk class and the manufacturer's annual revenue, and carries liability limits high enough for worst-case claims. Notified Bodies also review the policy's exclusions and territorial scope before accepting it as proof of financial coverage under Article 10(16) MDR.

Does a US-based manufacturer need a liability policy that covers the EU?

Yes. Under Article 11 MDR, manufacturers based outside the EU must maintain financial coverage applicable to claims arising in EU territories. This coverage is typically a prerequisite for EUDAMED registration and for cooperation with a Notified Body.

How often should a manufacturer review or renew their liability policy to stay compliant?

At least annually, and immediately whenever there are changes to product classification, sales volume, target markets, or business structure. Every update must be reflected in the QMS documentation and the risk management file.

What is medical device manufacturer liability insurance?

It is insurance that protects a manufacturer against civil liability for bodily injury or property damage caused by its product. It covers claims from patients, healthcare facilities and regulatory bodies following an incident, and proof of this financial coverage should be included in the QMS documentation under the responsibility of the PRRC.

Do MDR and IVDR legally require liability insurance?

Not explicitly. Article 10(16) MDR and Article 10(15) IVDR require manufacturers to maintain "sufficient financial coverage" proportionate to the device's risk class and the scale of operations, without naming liability insurance as the only way to meet it. In practice, an insurance policy is the most common way manufacturers demonstrate compliance, and MDCG 2022-16 lists adequate coverage as a factor that builds a Notified Body's confidence in a manufacturer's ability to manage liability.

What should a manufacturer liability insurance policy cover?

Coverage should include injuries caused by defective or poorly designed products, litigation costs, settlements and damages, and claims arising from foreseeable but improper use of the product. Manufacturers of active devices, implants, class D IVDs, or products exported to high-risk jurisdictions such as the US, Canada or parts of Asia should also add specific clauses for those risks.

 

What types of insurance do medical device manufacturers typically need?

The most common policies are product liability insurance (covering injuries after the product reaches the market), operational liability insurance (covering manufacturing, packaging and transport risks), and legal defence insurance (covering legal costs in disputes), often supplemented with clauses for non-EU exports or high-risk and implantable devices.

Are distributors and importers required to carry liability insurance under MDR?

No, MDR does not require distributors and importers to hold liability insurance. However, they can still be held liable for improper storage, transport, or failing to act when an incident occurs, which is why an increasing number of policies now extend coverage to EU Authorised Representatives and include recourse clauses among supply chain actors.

What happens if a manufacturer lacks adequate financial coverage?

Inadequate coverage can lead to the refusal or suspension of MDR/IVDR certification, full civil liability being covered from the company's own assets, loss of trust from Notified Bodies and business partners, and a breach of Article 10 MDR/IVDR that can trigger regulatory sanctions or product withdrawal. In the event of an incident, missing insurance can also prevent an effective Field Safety Corrective Action (FSCA) and force the manufacturer to destroy the product at its own expense.

How does Pure Clinical support manufacturers with insurance compliance under MDR/IVDR?

Pure Clinical helps select and negotiate insurance policies matched to the device's classification and intended purpose, integrates ISO 14971-based risk assessment with the technical documentation, prepares financial coverage documentation for audits, trains RA/QA teams on insurance as part of the quality system, and verifies that the policy meets MDCG 2022-16 and Notified Body requirements.